1. |
Interferon-&agr; preparations not all equal? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1050,
1996,
Page 2-2
&NA;,
Preview
|
PDF (1093KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
2. |
Attempts to curb the rise of drug-resistant pneumococci |
|
Inpharma Weekly,
Volume &NA;,
Issue 1050,
1996,
Page 3-4
Gill Higgins,
Preview
|
PDF (2196KB)
|
|
摘要:
A vaccine against pneumococci may be the best approach to overcoming the increasing incidence of multidrug-resistant (MDR) strains of this organism. Other approaches are also under investigation, including the use of multimeric &agr;-lactalbumin and the new cephalosporin cefepime. However, increasing the use of oral cephalosporins may exacerbate the problem, according to Professor Keith Klugman from the University of Witwatersrand, Johannesburg, South Africa. The views of Professor Klugman and other leading specialists in this field were presented at the 7th International Congress of Infectious Disease [Hong Kong; June 1996].
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
3. |
Long-acting calcium antagonists ‘safe’ in hypertension |
|
Inpharma Weekly,
Volume &NA;,
Issue 1050,
1996,
Page 4-4
&NA;,
Preview
|
PDF (1118KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
4. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1050,
1996,
Page 5-5
&NA;,
Preview
|
PDF (1034KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
5. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1050,
1996,
Page 6-6
&NA;,
Preview
|
PDF (1001KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
6. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1050,
1996,
Page 7-7
&NA;,
Preview
|
PDF (889KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
7. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1050,
1996,
Page 8-8
&NA;,
Preview
|
PDF (1066KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
8. |
Latest atypical antipsychotic agents move closer to approval |
|
Inpharma Weekly,
Volume &NA;,
Issue 1050,
1996,
Page 9-10
Andree Rose,
Preview
|
PDF (2171KB)
|
|
摘要:
The benefits of using conventional antipsychotic agents to treat schizophrenia are countered by the agents' lack of efficacy in treating negative symptoms and their association with the development of extrapyramidal symptoms (EPS). The introduction of the atypical antipsychotic clozapine, and later risperidone, marked a significant advance in the therapeutic options for schizophrenia. Now, another generation of atypical antipsychotic drugs looks set to reach the market. This will provide clinicians with a much greater range of options for treating schizophrenia by the end of the decade. Data on the newer antipsychotic drugs, and future prospects in schizophrenia treatment, were discussed at the 20th Collegium Internationale Neuro-Psychopharmacologicum (CINP) meeting [Melbourne, Australia; July 1996].
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
9. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1050,
1996,
Page 10-10
&NA;,
Preview
|
PDF (1080KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
10. |
Treating acute sinusitis in adults |
|
Inpharma Weekly,
Volume &NA;,
Issue 1050,
1996,
Page 11-11
&NA;,
Preview
|
PDF (959KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|